Chronic stimulation with SARS-CoV-2 spike protein does not trigger autoimmunity
Clinical Immunology · 2023
DOI: 10.1016/j.clim.2023.109264 ↗Kurz gefasst
Leserbrief in der Zeitschrift Clinical Immunology, 2023. Verfasst von Marc Scherlinger und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Beth Israel Deaconess Medical Center, Boston, MA, USA; Rheumatology department, Centre national de référence maladie auto-imm…. Hauptthemen laut MEDLINE: COVID-19, Autoimmune Diseases. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 10 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Fondation Bettencourt Schueller, Société Française d'Hématologie, Institut National de la Santé et de la Recherche Médicale.
Abstract (Originalsprache)
Autoimmune manifestations were reported in people infected with SARS-CoV-2. Repetitive exposure of mice to foreign antigen may lead to the onset of autoimmunity. We therefore investigated whether repetitive exposure to the SARS-CoV-2 spike protein could result in autoimmunity. To address this hypothesis, we repeatedly immunized C57Bl/6 mice with spike protein injected intraperitoneally. At the end of the immunization, mice which received spike protein produced anti-spike IgG but none of them developed anti-dsDNA antibodies or proteinuria. In conclusion, repetitive immunization with SARS-CoV-2 spike protein does not induce autoimmunity in the present mice model. Albeit reassuring, these results need to be confirmed by large epidemiological study evaluating the incidence of autoimmune diseases in individuals with repetitive SARS-CoV-2 antigen exposure.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicine, Beth Israel Deaconess Medical Center, Boston, MA, USA; Rheumatology department, Centre national de référence maladie auto-immunes et systémiques rares Est/Sud-Ouest (RESO), Strasbourg University…
- Rheumatology department, Centre national de référence maladie auto-immunes et systémiques rares Est/Sud-Ouest (RESO), Strasbourg University Hospital, Strasbourg University, France; Laboratoire d'ImmunoRhumatologie Moléc…
- Department of Medicine, Beth Israel Deaconess Medical Center, Boston, MA, USA.
- Rheumatology department, Centre national de référence maladie auto-immunes et systémiques rares Est/Sud-Ouest (RESO), Strasbourg University Hospital, Strasbourg University, France; Immunologie, Immunopathologie et Chimi…
Förderung
- Fondation Bettencourt Schueller
- Société Française d'Hématologie
- Institut National de la Santé et de la Recherche Médicale
Zitieren
APA
Scherlinger, M., Sibilia, J., Tsokos, G. C., & Gottenberg, J. E. (2023). Chronic stimulation with SARS-CoV-2 spike protein does not trigger autoimmunity. Clinical Immunology. https://doi.org/10.1016/j.clim.2023.109264
Vancouver
Scherlinger M, Sibilia J, Tsokos GC, Gottenberg JE. Chronic stimulation with SARS-CoV-2 spike protein does not trigger autoimmunity. Clinical Immunology. 2023. doi:10.1016/j.clim.2023.109264
BibTeX
@article{Scherlinger2023,
author = {Scherlinger, Marc and Sibilia, Jean and Tsokos, George C and Gottenberg, Jacques-Eric},
title = {Chronic stimulation with SARS-CoV-2 spike protein does not trigger autoimmunity},
journal = {Clinical Immunology},
year = {2023},
doi = {10.1016/j.clim.2023.109264}
}
EUVIMED